Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Researchers use ultrasound to predict ovarian cancer

Written by | 25 Mar 2022

The appearance of ovarian lesions on ultrasound is an effective predictor of cancer risk that can help women avoid unnecessary surgery, according to a new study published in… read more.

Mayo Clinic discovery in bone marrow cancer points to potential drug targets

Written by | 20 Mar 2022

New research from Mayo Clinic’s Center for Individualized Medicine finds that patients with ASXL1-mutant chronic myelomonocytic leukemia — an uncommon type of cancer of the bone marrow — have distinctive epigenetic changes… read more.

AI provides accurate breast density classification

Written by | 19 Mar 2022

An artificial intelligence (AI) tool can accurately and consistently classify breast density on mammograms, according to a study in Radiology: Artificial Intelligence. Breast density reflects the amount of fibroglandular… read more.

Endometriosis and ovarian cancer genetically tied

Written by | 17 Mar 2022

University of Queensland researchers have demonstrated a genetic link between endometriosis and ovarian cancer subtypes enabling them to identify potential drug targets for therapy and increasing the understanding… read more.

Diagnosis and self-help for ovarian cancer

Written by | 17 Mar 2022

It is a complete myth that ovarian cancer is a silent killer – even early-stage disease causes symptoms and knowing what they are is key to early treatment,… read more.

Ovarian cancer – facts and symptoms

Written by | 16 Mar 2022

Two thirds of UK women with ovarian cancer are diagnosed late when the cancer has spread and is difficult to treat.  IMI spoke to Dr Sharon Tate, Head… read more.

Initial treatment choice for prostate cancer doesn’t affect mental health outcomes

Written by | 13 Mar 2022

Depression and other mental health outcomes are similar for men choosing different options for initial treatment of localized prostate cancer, reports a study in The Journal of Urology®, an… read more.

Women dying of ‘ignorance’ as ovarian cancer crisis continues

Written by | 8 Mar 2022

March is ovarian cancer awareness month and 8th March is international women’s day – a good day to call for greater awareness, early diagnosis and prompt treatment of… read more.

Ovarian cancer in a nutshell

Written by | 1 Mar 2022

No fewer than 11 women die of ovarian cancer every day in the UK, equivalent to more than 4000 per annum.1 About 7,500 women are diagnosed with ovarian… read more.

Sandoz launches generic lenalidomide in 19 countries across Europe

Written by | 26 Feb 2022

Sandoz has announced the launch of generic oncology medicine lenalidomide, indicated for several haemato-oncology conditions as recommended by the latest European Society for Medical Oncology (ESMO) guidelines. The… read more.

Patients with rare skin cancer face 40% recurrence rate

Written by | 26 Feb 2022

Patients treated for Merkel cell carcinoma (MCC) face a five-year recurrence rate of 40% — markedly higher than the recurrence rates for cand other skin cancers, according to… read more.

Adjuvant darolutamide prolongs survival in metastatic, hormone-sensitive prostate cancer

Written by | 25 Feb 2022

Researchers from a phase 3 clinical trial report that addition of the androgen-receptor inhibitor darolutamide to androgen-deprivation therapy and chemotherapy significantly prolongs the survival of men with metastatic,… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.